Health
ASG Superconductors with HZDR combine magnetic resonance imaging with proton therapy
Towards live imaging in cancer therapy GENOA, Italy, April 19, 2021 /PRNewswire/ -- ASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world's first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy, comb...
2021-04-19 22:56
2439
AACR Annual Meeting 2021: AnchorDx Unveils High-Performance Blood Test for Gastric Cancer Screening
GUANGZHOU, China, April 19, 2021 /PRNewswire/ -- At this year's American Association for Cancer Research (AACR) Annual Meeting 2021 (April 10-15), molecular diagnostic company AnchorDx presented a poster (Poster 2610) unveiling its Aurora 2.0 study results. The poster introduced the company's up...
2021-04-19 21:00
2135
China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port
HAIKOU, China, April 19, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, commented on the policy statements in "Several Special Measures to Support the Construction of Hainan Free Trade Port to Rel...
2021-04-19 20:30
3062
CNPharm has succeeded in maintaining IC100 for 24 hours with one injection
- Trail-blazing diversification of the repurposing of Niclosamide - Full-scale clinical preparation of injections for severely ill patients SEOUL, South Korea, April 19, 2021 /PRNewswire/ -- Hyundai Bioscience (Symbol 048410), a KOSDAQ listed company, announced on the 19th that its major sharehol...
2021-04-19 20:15
1608
PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBC
DAEJEON, South Korea, April 19, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company has entered into an agreement with MSD to initiate a Phase II combination trial of olin...
2021-04-19 20:00
1503
Happiness Biotech Officially Launched Cross-Border E-commerce Platform- Happy Buy International
NANPING, China, April 19, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer and e-commerce services provider, announced today that the Company has officially launched cross-border e-commerc...
2021-04-19 20:00
5011
Porton Biologics Announces Closing Series-A Financing to Drive Commercial Production of Gene and Cell Therapy
SUZHOU, China, April 19, 2021 /PRNewswire/ -- On April 16, 2021, Suzhou Porton BiologicsLtd. (hereinafter referred to as Porton Biologics), a subsidiary of Porton Pharma Solutions Ltd. (hereinafter referred to as Porton Pharma Solutions) (300363.SZ), which focuses on gene and cell therapy CDMO se...
2021-04-19 20:00
4503
Kazia Licenses Global Rights to EVT801, a Novel, First-in-Class, Clinic-Ready, VEGFR3 Inhibitor, from Evotec SE
SYDNEY, April 19, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce that it has entered into a worldwide exclusive licensing agreement and a master services agreement with Evotec SE (FRA: EVT), a leading ...
2021-04-19 17:54
3490
RDIF and Hualan Biological Bacterin agree to produce over 100 million doses of the Sputnik V vaccine in China
MOSCOW, April 19, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Hualan Biological Bacterin Inc. (a subsidiary company of one ofChina's leading biopharmaceutical producers and the largest influenza vaccine manufacturer, Hualan Biological Enginee...
2021-04-19 17:16
4065
200 Days to the fourth CIIE
SHANGHAI, April 19, 2021 /PRNewswire/ -- Preparations are in full swing for the
fourth China International Import Expo (CIIE), the world's largest import expo,
which is just 200 days away fromApril 18.
2021-04-19 08:00
373
Transcenta Announced Successful First Patient Dosed in Phase I Clinical Study of TST001 Combined with CAPOX for the Treatment of Patients with First-line Locally Advanced Unresectable or Metastatic Gastric Cancer
SUZHOU, China, April 18, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the first patient has been success...
2021-04-19 08:00
1729
Adapting to change: sustaining care in a new world
World Hemophilia Day 2021 MONTRÉAL, April 17, 2021 /PRNewswire/ -- April 17, 2021 is World Hemophilia Day. The theme of the event this year is "Adapting to change: sustaining care in a new world". This important event is about bringing the global bleeding disorders community together. With the ...
2021-04-17 17:00
2614
IMG Says 71% of U.S. International Travelers Are Planning to Travel Abroad in 2021
- IMG's Future of Travel Survey collected responses from their U.S. members with past international travel experience (42% of respondents reported 3+ international trips per year) - Survey results reveal travel insights such as willingness to travel internationally, importance of safety precauti...
2021-04-16 21:30
3023
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
SEOUL, South Korea and JINAN, China, April 16, 2021 /PRNewswire/ -- Peptron, Inc. ("Peptron", KOSDAQ: 087010), aSouth Korea-based biotech company, and Qilu Pharmaceutical ("Qilu"), a leading vertically integrated pharmaceutical company focused on discovering, developing, manufacturing and commerc...
2021-04-16 20:00
4003
Kintor Pharmaceuticals Announced Successful Dosing of the First Batch of Patients for Acne Vulgaris Phase I/II Clinical Trial of Pyrilutamide
SUZHOU, China, April 16, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939), a clinical-stage biotechnology company developing small molecule and biological therapeutics, announced today the clinical trial of Pyrilutamide as a treatment for the acne vulgaris has completed the first b...
2021-04-16 18:29
5485
Chipscreen received a Phase 1b/2 clinical trial of Chiauranib/CS2164 IND clearance from the US Food and Drug Administration (FDA)
SHENZHEN, China, April 16, 2021 /PRNewswire/ -- Shenzhen Chipscreen Biosciences , aChina headquartered biopharmaceutical company developing and marketing novel drugs based on its unique technology of Chemical Genomics Drug discovery platform, today announces that it has received Investigational Ne...
2021-04-16 18:24
2212
Report from the Extraordinary General Meeting 2021 in Elekta
STOCKHOLM, April 16, 2021 /PRNewswire/ -- Elekta AB (publ) (EKTA-B.ST) has held an Extraordinary General Meeting on Friday16 April 2021. Due to Covid-19, the Meeting was conducted by advance postal vote, without the physical attendance of shareholders, representatives or third parties. A summary ...
2021-04-16 16:59
7016
Radcliffe Cardiology Launches New Title: JAPSC: Journal of Asian Pacific Society of Cardiology on Behalf of the Asian Pacific Society of Cardiology
LONDON, April 16, 2021 /PRNewswire/ -- The Asian Pacific Society of Cardiology and Radcliffe Cardiology are pleased to announce the launch of a new open access title,JAPSC: Journal of Asian Pacific Society of Cardiology. Launching in 2021, JAPSC will be led by Dr Yeo Khung Keong as Editor-in-Chie...
2021-04-16 13:00
1801
GT Apeiron Therapeutics Strengthens Advisory Board
SHANGHAI, April 16, 2021 /PRNewswire/ -- Keith Lenden and Dr. Honggang Bi has been appointed as new members of the Advisory Board at GT Apeiron Therapeutics, an AI empowered drug discovery start-up developing oncology therapeutics. Mr. Lenden and Dr. Bi add further expertise in drug discovery inn...
2021-04-16 09:00
1999
Transcenta Announced Presentation of Preclinical Data of TST005 at 2021 AACR Virtual Annual Meeting
SUZHOU, China, April 15, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, presented preclinical data of TST005, a bi-functio...
2021-04-16 08:00
1319
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 293 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
[Picked up by 279 media titles]
2024-11-08 20:11
Most Read
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5652
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
2024-11-11 21:00
5652
Sobot Introduces its All-in-One Solution at GITEX Global 2024
2024-11-12 11:00
5608